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Sch 29482, laboratory evaluation of a new penem antibiotic
F. H. Kayser and I. Kuhn
Institute of Medical Microbiology, University of Zurich, 8028 Zurich, Switzerland
The antibacterial activity of a new penem antibiotic, Sch 29482 (SCH), was examined
in comparison with appropriate cephalosporins and penicillins. The drug inhibited
penicillinase-positive and negative staphylococci equally well, being 2-5 times more
active than cephalothin or cefamandole and 10-20 times more active than methicillin.
Staphylococci resistant to methicillin were susceptible to SCH in agar dilution tests.
Staphylococci tolerant to methicillin were also tolerant to SCH. Streptococci and
pneumococci were highly susceptible to the drug. The agent was of only moderate
activity against enterococci, especially Streptococcus faecium strains. MICs of
ampicillin and penicillin G against enterococci were 4-8 times lower than those of
SCH. SCH was bactericidal. Neither the choice of the method used for susceptibility
testing, nor the size of the inoculum nor various test media influenced the in-vitro
activity of this drug against a representative collection of Gram-negative and Gram-
positive bacteria.
Introduction
Sch 29482 (SCH) is a new penem antibiotic which is chemically related to the carbapenem
antibiotic thienamycin. The present study was undertaken to compare the in-vitro
efficacy of this drug with various other /Mactam antibiotics. Some 250 clinical isolates of
Gram-positive cocci were included in the study to provide a good indication of the
potential efficacy of SCH in clinical application for Gram-positive infections. With a
representative number of Gram-negative and Gram-positive bacteria, the influence of
various in-vitro parameters, such as method of susceptibility testing, test medium and
inoculum size, on results obtained with SCH was examined. All our data emphasize the
fact that this penem antibiotic possesses promising in-vitro characteristics and,
therefore, warrants further laboratory and clinical evaluation.
Methods
Bacteria
The micro-organisms used were isolated from clinical material and identified according
to standard procedures. About 250 Gram-positive organisms were examined. The
collection of Gram-negative bacteria included: Escherichia coli (16 strains); Klebsiella
pneumoniae (8 strains) ; Enterobacter aerogenes (4 strains); Enterobacter cloacae (4
strains); Serratia marcescens (5 strains); Proteus mirabilis (4 strains); Proteus vulgaris (4
strains); Providentia rettgeri (4 strains); Morganella morganii (4 strains) and
Acinetobacter calcoaceticus (4 strains).
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Antibiotics
Stock solutions of SCH, methicillin, penicillin G, ampicillin, cephalothin, cefamandole,
cefaclor, cephalexin, cefoperazone and N-formimidoyl thienamycin were prepared in
sterile distilled water and either used immediately or stored at -80°C, if necessary. All
drugs were kindly provided by the pharmaceutical companies.
Susceptibility tests
Minimal inhibitory concentrations (MICs) were determined by serial twofold dilutions
of antibiotics, usually in Mueller-Hinton agar (BBL), or in other broth or agar media as
indicated in the text. Pneumococci and haemolytic streptococci were tested on agar
containing 1% (w/v) Isovitalex (BBL) and 1% (w/v) haemoglobin (BBL). The inoculum
in agar dilution was about 104 per spot, and in micro-broth dilution 5 x 10s to 106 per
ml MICs were read after incubation at 37°C for 18 to 24 h. The MIC techniques
corresponded to the procedures proposed by the National Committee of Clinical
Laboratory Standards (1980).
Minimal bactericidal concentrations (MBCs) were determined by subculturing
approximately 5 y\ of the medium in each well of an MIC plate on Mueller-Hinton
agar. The MBC was the lowest concentration of antibiotic that caused a 99-9%
reduction in the number of viable organisms.
Populations of methicillin-resistant staphylococci were analysed by disaggregation of
overnight broth cultures (brief, controlled exposure to 20-kilocycle sound) and surface
inoculation of appropriate dilutions on drug-containing Mueller-Hinton agar plates.
Colony counts after 48 h of incubation at 30 or 37°C allowed calculation of the number
of viable units among 108 colony forming units (cfu) resistant to each concentration of
antimicrobial agent.
Tolerance in staphylococci was examined by plating 20 ^ 1 of each well of an MIC
plate on Mueller-Hinton agar and counting the number of cfu. Kinetics of killing was
investigated in 20 ml Mueller-Hinton broth, to which 100 times the MIC of drug was
added. At appropriate time intervals, 0-4 ml samples were withdrawn, and incubated for
10 to 15 min at 20°C with 01 ml of a crude Bacillus cereus enzyme preparation (Sabath
et al., 1971). This served to destroy any drug and, thus to avoid carry-over of
bacteriostatic activity. Destruction of drug in the broth was examined by a plate assay,
using Bacillus subtilis ATCC 6633 as test organism (Bennet et al., 1966).
Results
Activity against Gram-positive organisms
Table I summarizes MIC data of SCH against Gram-positive bacteria. As can be seen,
the drug showed excellent activity against staphylococci and streptococci including the
pneumococci. The drug showed activity against methicillin-resistant staphylococci also.
Enterococci, especially Str. faecium, were not very susceptible to the agent. However,
the incidence of Str. faecium among enterococci is only 1-8% in our area.
Table II compares the activity of various /J-lactam antibiotics against Staphylococcus
aureus (N = 35), Staph. epidermidis (N = 48) and methicillin-resistant Staph. aureus
(N = 40). Staph. epidermidis includes coagulase-negative organisms. No further
speciation was done. SCH proved to be highly active against penicillinase-positive
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Table I. Activity of Sch 29482 against Gram-positive bacteria
Organism
Staphylococcus
Methicillin-resistant
Penicillinase-positive
Penicillinase-negative
Streptococcus faecalis
Streptococcus faecium
Streptococcus durans
Haemolytic streptococci
Group A
Group B
Group C
Pneumococci
No.
of
strains
40
51
32
31
14
3
25
9
7
Minimal inhibitory
concentration (mg/1)
Mean
0-26
008
008
7-6
19-5
5 0
003
0-12
014
Mode
0-25
0125
006
80
wide range
8 0
003
012
012
MIC9
0-46
014
01
9-3
78
6-5
004
013
0-71
30 001 003 007
•Concentration required to inhibit 90% of the strains examined.
Table II. Comparative activity of /Mactam antibiotics against Staph. aureus (N = 35), Staph.
epidermidis (N = 48), and methicillin-resistant Staph. aureus (N = 40)
Antibiotic
SCH
Methicillin
Penicillin G
Cephalothin
Cefamandole
Cefaclor
Cefoperazone
N-Formimidoyl
thienamycin
SCH
(30°C)
Penicillinase
positive
MIC (mean)
008
20
0-2
0-34
4-22
1-33
003
—
Penicillinase
negative
MIC (mean)
008
1-2
002
016
0-24
1 96
102
003
—
Methicillin-resistant
MIC (mean) MIC
 90*
0-26
4-8
0-9
1-9
33-7
8-7
008
1-6
0-46
7-2
2-5
4-8
73
18-7
01
4
•Concentration required to inhibit 90% of the examined strains.
Incubation was carried out at 37°C, unless otherwise indicated, for 24 h.
and negative strains. Only the thienamycin compound had similar activity. SCH and
thienamycin also showed activity against methicillin-resistant organisms, when tested in
agar dilution with an inoculum of 10* per spot and incubated for 24 h at 37°C. These
two drugs were more active than cefamandole or cephalothin, which were shown
elsewhere to be the most active /Mactam drugs against methicillin-resistant
staphylococci (Kayser, 1980). Incubation of plates at 30°C increased MICs of SCH
approximately 10 times.
184 F. H. Kayser and I. Kuhn
8
§
~ 6
(J
_ 5
o
1 «
•5 3
s
F l
z
~izHZ
SCH^
(37°C;48h)
1 -1 r
' L_
^SCH
(30°C;
48 h)
1
Oxocillin
<
"(37°C;48 h)
1—1
1
<-Cefomondole 1
,(37°C; 46
1
 1
1
h)
-
0 03 0-06 0125 025 0-5 1 2 4 B 16 32 64 128 256
Antibiotic (mg/l)
Figure 1. Composition of highly methicillin-resistant Staph. aureus strain EK 695 of cells with different
levels of resistance to SCH, cefamandole and oxacillin
It is well known that populations of methicillin-resistant staphylococci are composed
of cells differing widely in their resistance to /Mactam antibiotics. This heterogeneity was
also observed in case of SCH (see Figure 1). However, the resistant minorities in
populations are less resistant to SCH than to oxacillin or cefamandole.
Penicillin-tolerant staphylococci are known to be susceptible to penicillins in MIC
tests, but highly resistant to the killing effect of these drugs (Sabath et al., 1977). We
examined the tolerance phenomenon in 32 Staph. aureus and epidermidis strains (16 of
each species) against methicillin and SCH. Only one Staph. aureus culture was found to
be tolerant to the two drugs. Figure 2 demonstrates the kinetics of killing of the tolerant
icr
Staph. aureus,
tolerant
8 12 16
Incubation ( h )
20 24
Figure 2. Rates of killing of Staph. aureus strain FK. 484 and FK 485 by methicillin and SCH. Strain
FK 484: • methicillin 60 mg/l, A SCH 6 mg/l; strain FK 485: O methicillin 60 mg/l, A SCH 6 mg/l.
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Table HI. Comparative activity of /J-lactam antibiotics against enterococci (N = 48)
Minimal inhibitory concentration (mg/1)
Antibiotic Mean
SCH
Penicillin G
Ampicillin
Methicillin
Cephalothin
Cefamandole
Cefaclor
Cefoperazone
N-Formimidoyl
thienamycin
9-8
21
0-7
34-9
34-4
29-8
1190
28-5
4-3
lode
8
2
1
32
32
32
128
32
MIC90*
300
100
2-9
1570
1300
1000
2200
900
80
Concentration required to inhibit 90% of the examined strains.
and a non-tolerant strain by methicillin and SCH. Destruction of drugs during growth
of the tolerant culture in comparison with the non-tolerant culture did not occur.
Table HI summarizes MIC data of /?-lactam antibiotics against enterococci. Although
SCH was not as active as penicillin or ampicillin against enterococci, it showed some
activity, which was about 4 times greater than the activity of cephalosporins.
Thienamycin also proved to have a moderate activity against these problem bacteria.
All drugs were active against /J-haemolytic streptococci and pneumococci (see
Table IV). Penicillin G and thienamycin were most active, closely followed by SCH,
ampicillin and cefamandole.
Examination of bactericidal activity of SCH gave MBC values which were identical
to MICs against most of 80 Gram-positive strains examined. MBCs for methicillin-
resistant staphylococci were 4-16 times, and for the tolerant Staph. aureus culture, more
Table IV. Comparative activity of /Mactam antibiotics against streptococci and pneumococci
Antibiotic
SCH
Penicillin G
Ampicillin
Methicillin
Cephalothin
Cefaclor
Cefalexin
Cefamandole
Cefoperazone
TV-Form imidoyl
thienamycin
Group A
(W =25)
003
0004
001
013
0-25
0-25
0-5
003
013
< 0 0 3
Mode
Group B
(N = 9)
013
003
01
0-5
0-25
80
8 0
013
0-25
sSO-03
MIC (mg/1)
Group C
(JV=7)
013
001
003
0-25
0-25
20
2 0
006
0-25
«=003
Pneumococci
(N = 30)
003
0008
001
006
006
0-25
10
006
006
<003
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Table V. Effect of methods and media on in-vitro activity of Sch 29482
Method and
medium
Agar dilution
procedure (NCCLS)
Mueller-Hinton-Agar
(Oxoid)
Isosensitest-Agar
(Oxoid)
Diagnostic Sensitivity
Test-Agar (Oxoid)
Micro-broth dilution
procedure (NCCLS)
Mueller-Hinton broth
(Oxoid)
Mueller-Hinton broth
plus cation supplement
(see NCCLS)
Minimal
Enterobacteru
(N = 67)
091
0-85
0-93
108
1 37
inhibitory concentration
i Staphylococci
(N = 32)
012
010
007
0-25
016
(mean) (mg/1)
Enterococci
(tf = 8)
5-7
4-4
6-2
6-8
9-8
than 100 times higher than MICs. Killing of Staph. aureus and enterococci was often less
effective at higher drug concentrations.
In-vitro factors and activity of SCH
/Mactam antibiotics are known to be of varying stability to /J-lactamases. Instability of a
drug to a /Mactamase can result in wide differences in MIC results according to the
method used. Instability also can result in a significant inoculum effect. Activity of
antimicrobials in vitro can also be influenced by the composition of the test medium. We,
therefore, examined the influence of some in-vitro parameters on results obtained with
SCH. The enterobacteria used for these tests were a representative collection of
organisms as described in the 'Methods' section. Table V demonstrates that neither the
method nor various media influenced MIC results of SCH. Table VI shows that the size
of the inoculum also had no effects on test results. The only exceptions were methicillin-
resistant staphylococci. Because of the typical heterogeneity (see Figure 1), MICs for
methicillin-resistant staphylococci were greater at higher inoculum sizes.
Discussion
The penem antibiotic SCH has been shown in this study to be an excellent antibiotic
against most species of Gram-positive organisms. In particular it exhibited some activity
against methicillin-resistant staphylococci, although the typical characteristics of these
bacteria—heterogeneity and influence of incubation temperature on phenotypic
expression of resistance—were also observed with SCH. The drug was as active as
penicillin G against penicillinase-negative variants of methicillin-resistant strains (data
were not shown here) and, thus can be considered as a possible choice in the treatment
of infections caused by such bacteria. This might be important in the future, because
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Table VI. Effect of inoculum size on activity of Sch 29482
Organism
Enterobacteria
(N= 10)
Staphylococci
Staph. aureus
(methicillin-resistant)
(AT = 2 )
Enterococci
(AT = 5 )
Enterobacteria
Staphylococci
Staph. aureus
(methicillin-resistant)
Enterococci
103/spot
0-34
003
0-50
3-5
104/ml
0-28
009
0-70
4-60
Mean MIC (mg/1)
107spot
0-45
013
0-70
4-6
Mean MIC (mg/1)
105/ml
0-23
008
2-80
610
in agar dilution
105/spot
110
016
16
61
in broth dilution
106/ml
0-45
017
400
5-30
106/spot
1-40
0-25
32
7 0
107/ml
0-37
0-25
9000
1210
there is a world-wide increase of epidemic infections in hospitals caused by
staphylococci, simultaneously resistant to /?-lactam antibiotics, aminoglycosides and
other antimicrobials (Shanson, Kensit & Duke, 1976; Crossley et al., 1979; Graham et
al., 1980; Amirak et al, 1981. Kayser, F. H., 1981 personal observation). SCH has also
been shown to be highly active against streptococci and pneumococci. Enterococci,
however, were not as susceptible to SCH as to ampicillin or penicillin G, although they
were more sensitive to this agent than to cephalosporin antibiotics. The good activity of
SCH against the small collection of Gram-negative bacteria suggests that this drug has a
broad antibacterial spectrum of activity.
Neither the size of the inoculum, the method used for susceptibility testing nor various
test media affected the in-vitro activity of SCH against Gram-negative and Gram-
positive bacteria. Such parameters can influence susceptibility testing of bacteria against
/Mactam antibiotics that have a reduced stability to /J-lactamases. It was shown, for
instance, that the in-vitro activity of cefoperazone, cefamandole and cephalothin against
Gram-negative bacteria producing large amounts of TEM-/Mactamase, is highly
dependent on the test method and the size of the inoculum used (Kayser, Huf &
Homberger, 1981). Since such TEM-producers were among the strains examined and
since neither the inoculum nor the method influenced the activity of SCH against these
strains, it can be concluded that this drug is remarkably stable against the most frequently
occurring /Mactamase of Gram-negative bacteria (Mathew, 1979).
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